Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · IEX Real-Time Price · USD
7.96
-0.15 (-1.85%)
At close: Jul 19, 2024, 4:00 PM
7.90
-0.06 (-0.75%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $186.31 million as of July 22, 2024. Its market cap has decreased by -56.53% in one year.
Market Cap
186.31M
Enterprise Value
183.82M
1-Year Change
-56.53%
Ranking
Category
Stock Price
$7.96
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has increased from $97.40M to $186.31M, an increase of 91.28%. That is a compound annual growth rate of 8.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 186.30M | 81.76% |
| Dec 29, 2023 | 102.50M | -58.42% |
| Dec 30, 2022 | 246.50M | -19.18% |
| Dec 31, 2021 | 305.00M | 84.51% |
| Dec 31, 2020 | 165.30M | 828.65% |
| Dec 31, 2019 | 17.80M | -58.12% |
| Dec 31, 2018 | 42.50M | 28.01% |
| Dec 29, 2017 | 33.20M | -53.24% |
| Dec 30, 2016 | 71.00M | -27.10% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EDAP TMS | 189.23M |
| Lineage Cell Therapeutics | 188.82M |
| Fractyl Health | 188.71M |
| Coherus BioSciences | 188.15M |
| Inhibrx | 186.45M |
| 908 Devices | 185.88M |
| Seres Therapeutics | 185.52M |
| OptimizeRx | 183.06M |